We use cookies to offer you the best experience on our website. Learn more about the cookies we use and how you can manage them. Please review our information access procedures and our Privacy Statement. By clicking the "X" to remove this notice and/or continuing without changing your settings, you agree to our use of cookies.

  • 1 800 260 6682

  • GTranslate

Live in Nova Scotia
The Labs
The Labs

The Labs is more than just space and infrastructure. It’s a community.
« Back
Export from Nova Scotia
Export Development Program
Export Development Program

The Export Development Program supports businesses to increase sales outside of Nova Scotia and improve competitiveness.
« Back
Invest in Nova Scotia
Business Development Incentives
Business Development Incentives

Expanding a business? We have incentives and competitive costs to meet your needs.
« Back
Do Business in Nova Scotia
Business Licenses & Permits
Business Licenses & Permits

Find information on starting and operating a business in Nova Scotia at the Access Nova Scotia website. Take a look.
« Back

Other ways to reach us: 1.800.260.6682 | 902.424.8670 | info@investnovascotia.ca

  • Home
  • Articles
  • ABK Biomedical Announces FDA 510(k) Clearance for Easi-Vue Embolic Microspheres

ABK Biomedical Announces FDA 510(k) Clearance for Easi-Vue Embolic Microspheres

Monday, September 12, 2022

ABK Biomedical, an Innovacorp portfolio company, has announced FDA 510(k) clearance of Easi-Vue embolic microspheres for the treatment of patients suffering from arteriovenous malformations and hypervascular tumors. Read ABK's press release.

September 12, 2022, Halifax, Nova Scotia

Categories

Start-up

Invest Nova Scotia © 2024